Analysts Set Omega Healthcare Investors, Inc. (NYSE:OHI) Price Target at $41.10

Shares of Omega Healthcare Investors, Inc. (NYSE:OHI) have received a consensus recommendation of “Moderate Buy” from the eleven brokerages that are presently covering the stock, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and six have assigned a buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $41.10.

OHI has been the subject of a number of research analyst reports. Berenberg Bank initiated coverage on Omega Healthcare Investors in a research report on Friday, October 18th. They set a “buy” rating and a $45.00 price objective for the company. Royal Bank of Canada raised their price objective on Omega Healthcare Investors from $39.00 to $43.00 and gave the company a “sector perform” rating in a research report on Monday, November 11th. BNP Paribas upgraded Omega Healthcare Investors from a “neutral” rating to an “outperform” rating and set a $49.00 price objective for the company in a research report on Thursday, October 31st. BMO Capital Markets upgraded Omega Healthcare Investors from a “market perform” rating to an “outperform” rating and set a $45.00 price objective for the company in a research report on Monday, December 9th. Finally, Wells Fargo & Company reiterated an “overweight” rating and issued a $43.00 price target (up previously from $40.00) on shares of Omega Healthcare Investors in a research report on Tuesday, October 1st.

Institutional Trading of Omega Healthcare Investors

Several institutional investors have recently added to or reduced their stakes in OHI. Daiwa Securities Group Inc. lifted its stake in Omega Healthcare Investors by 317.7% in the third quarter. Daiwa Securities Group Inc. now owns 3,949,368 shares of the real estate investment trust’s stock worth $160,739,000 after purchasing an additional 3,003,845 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Omega Healthcare Investors by 328.6% during the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 1,661,964 shares of the real estate investment trust’s stock valued at $67,642,000 after acquiring an additional 1,274,238 shares in the last quarter. Marshall Wace LLP bought a new stake in shares of Omega Healthcare Investors during the second quarter valued at approximately $20,962,000. FMR LLC raised its stake in shares of Omega Healthcare Investors by 9.9% during the third quarter. FMR LLC now owns 4,216,835 shares of the real estate investment trust’s stock valued at $171,625,000 after acquiring an additional 380,626 shares in the last quarter. Finally, Franklin Resources Inc. raised its stake in shares of Omega Healthcare Investors by 441.4% during the third quarter. Franklin Resources Inc. now owns 429,993 shares of the real estate investment trust’s stock valued at $17,177,000 after acquiring an additional 350,570 shares in the last quarter. Institutional investors own 65.25% of the company’s stock.

Omega Healthcare Investors Trading Up 2.7 %

Shares of Omega Healthcare Investors stock opened at $38.21 on Thursday. The firm has a market cap of $10.31 billion, a price-to-earnings ratio of 28.09, a PEG ratio of 1.08 and a beta of 0.99. The business has a 50-day moving average price of $38.54 and a 200-day moving average price of $38.98. The company has a quick ratio of 6.48, a current ratio of 6.48 and a debt-to-equity ratio of 1.10. Omega Healthcare Investors has a twelve month low of $27.53 and a twelve month high of $44.42.

Omega Healthcare Investors Company Profile

Omega Healthcare Investors, Inc engages in the provision of financing and capital to the long-term healthcare industry with a particular focus on skilled nursing facilities, assisted living facilities, independent living facilities, rehabilitation and acute care facilities, and medical office buildings.